EP3328437A4 - Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation - Google Patents

Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation Download PDF

Info

Publication number
EP3328437A4
EP3328437A4 EP16830853.4A EP16830853A EP3328437A4 EP 3328437 A4 EP3328437 A4 EP 3328437A4 EP 16830853 A EP16830853 A EP 16830853A EP 3328437 A4 EP3328437 A4 EP 3328437A4
Authority
EP
European Patent Office
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16830853.4A
Other languages
German (de)
English (en)
Other versions
EP3328437A1 (fr
Inventor
Bong Oh Kim
Kyu Jin Kyung
Ji Yeong Kim
Hye Rim Kim
Bum Chan MIN
Yoo Jeong YOON
Min Hyo Seo
Yil Woong Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samyang Biopharmaceuticals Corp
Original Assignee
Samyang Biopharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals Corp filed Critical Samyang Biopharmaceuticals Corp
Publication of EP3328437A1 publication Critical patent/EP3328437A1/fr
Publication of EP3328437A4 publication Critical patent/EP3328437A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP16830853.4A 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation Withdrawn EP3328437A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106629 2015-07-28
PCT/KR2016/008270 WO2017018820A1 (fr) 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation

Publications (2)

Publication Number Publication Date
EP3328437A1 EP3328437A1 (fr) 2018-06-06
EP3328437A4 true EP3328437A4 (fr) 2019-03-20

Family

ID=57884713

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16830853.4A Withdrawn EP3328437A4 (fr) 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation

Country Status (13)

Country Link
EP (1) EP3328437A4 (fr)
JP (1) JP2018521105A (fr)
KR (1) KR101787453B1 (fr)
CN (1) CN107466231A (fr)
AU (1) AU2016299548A1 (fr)
BR (1) BR112018001737A2 (fr)
CA (1) CA2993928A1 (fr)
HK (1) HK1249441A1 (fr)
IL (1) IL257187A (fr)
MX (1) MX2018001223A (fr)
RU (1) RU2018107055A (fr)
WO (1) WO2017018820A1 (fr)
ZA (1) ZA201801187B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101787447B1 (ko) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
KR101787451B1 (ko) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085216A1 (fr) * 2000-05-12 2001-11-15 Samyang Corporation Procede de preparation de micelle polymere via une separation de phases d'un copolymere sequence
WO2001087345A1 (fr) * 2000-05-17 2001-11-22 Samyang Corporation Composition medicamentseuse du type micelle polymere stable et son procede de preparation
US20100280214A1 (en) * 2007-12-31 2010-11-04 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
US20130345297A1 (en) * 2007-12-31 2013-12-26 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020507A (en) 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
US7879317B2 (en) * 2001-10-18 2011-02-01 Samyang Corporation Polymeric micelle compositions with improved stability and methods of making thereof
WO2005037840A1 (fr) 2003-10-16 2005-04-28 Mayne Pharma (Usa), Inc. Methode pour inverser le groupe hydroxyle c2' d'esters de taxane
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
EP2201935B1 (fr) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Composition de micelles polymères contenant un médicament faiblement soluble et son procédé de préparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085216A1 (fr) * 2000-05-12 2001-11-15 Samyang Corporation Procede de preparation de micelle polymere via une separation de phases d'un copolymere sequence
WO2001087345A1 (fr) * 2000-05-17 2001-11-22 Samyang Corporation Composition medicamentseuse du type micelle polymere stable et son procede de preparation
US20100280214A1 (en) * 2007-12-31 2010-11-04 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
US20130345297A1 (en) * 2007-12-31 2013-12-26 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KIM S C ET AL: "In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 72, no. 1-3, 14 May 2001 (2001-05-14), pages 191 - 202, XP027296131, ISSN: 0168-3659, [retrieved on 20010514] *
See also references of WO2017018820A1 *
ZHU K J ET AL: "PREPARATION, CHARACTERIZATION, AND PROPERTIES OF POLYLACTIDE (PLA)-POLY(ETHYLENE GLYCOL) (PEG) COLOYMERS: A POTENTIAL DRUG CARRIER", JOURNAL OF APPLIED POLYMER SCIENCE, JOHN WILEY & SONS, INC, US, vol. 39, no. 1, 1 January 1990 (1990-01-01), pages 1 - 09, XP000650366, ISSN: 0021-8995, DOI: 10.1002/APP.1990.070390101 *

Also Published As

Publication number Publication date
CN107466231A (zh) 2017-12-12
WO2017018820A1 (fr) 2017-02-02
JP2018521105A (ja) 2018-08-02
KR101787453B1 (ko) 2017-10-19
EP3328437A1 (fr) 2018-06-06
RU2018107055A (ru) 2019-08-28
RU2018107055A3 (fr) 2019-08-28
AU2016299548A1 (en) 2018-02-22
IL257187A (en) 2018-03-29
HK1249441A1 (zh) 2018-11-02
ZA201801187B (en) 2018-12-19
BR112018001737A2 (pt) 2018-09-11
MX2018001223A (es) 2018-11-09
CA2993928A1 (fr) 2017-02-02
KR20170015200A (ko) 2017-02-08

Similar Documents

Publication Publication Date Title
EP3453707A4 (fr) Dérivé de benzazépine, procédé pour le préparer, composition pharmaceutique et son utilisation
EP3486242A4 (fr) Dérivé d'oxopicolinamide, son procédé de préparation et son utilisation pharmaceutique
EP3357491A4 (fr) Composition pharmaceutique contenant un médicament anionique, et son procédé de préparation
EP3404024A4 (fr) Dérivé de quinazolinone, son procédé de préparation, composition pharmaceutique, et applications associées
EP3339305A4 (fr) Dérivé d'indole, son procédé de préparation et son utilisation dans un médicament pharmaceutique
EP3431471A4 (fr) Composé de cyclopropylamine fluorée, procédé de préparation de ce dernier, composition pharmaceutique basée sur ce dernier, et utilisations de ce dernier
EP3342801A4 (fr) Procédé de préparation d'une résine superabsorbante, et résine superabsorbante
EP3360878A4 (fr) Dérivé d'azétidine, son procédé de préparation et son utilisation
EP3546489A4 (fr) Polypropylène et son procédé de préparation
EP3398615A4 (fr) Composition pharmaceutique mucoadhésive et son procédé de préparation
EP3305310A4 (fr) Formulation virale oncolytique et son procédé de préparation
EP3309217A4 (fr) Composition de polycarbonate et son procédé de préparation
EP3498716A4 (fr) Composé thiénopyrimidine, son procédé de préparation, composition pharmaceutique et applications associées
EP3466946A4 (fr) Thiophène, son procédé de fabrication, et application pharmaceutique correspondante
EP3510058A4 (fr) Composition de polymérisation, son procédé de préparation et articles la comprenant
EP3398958A4 (fr) Polyamino-acide, conjugué protéine-polyamino-acide et procédé de préparation correspondant
EP3556769A4 (fr) Dérivé de polyximine, procédé de préparation et application associés
EP3323440A4 (fr) Matériau poreux et son procédé de préparation
EP3438105A4 (fr) Composé de diaryl-b-lactame et son procédé de préparation et utilisation pharmaceutique associée
EP3541459C0 (fr) Canule, système d'assistance ecmo
EP3328368A4 (fr) Composés et composition pharmaceutique associée au système d'ubiquitination-protéasome
EP3402470A4 (fr) Composition pharmaceutique stable
EP3388433A4 (fr) Dérivé de phthalazine et procédé de préparation, composition pharmaceutique et utilisation associées
EP3412286A4 (fr) Composition médicamenteuse et préparation pharmaceutique à base de taxol, procédé de préparation de ces dernières, et utilisation de ces dernières
EP3391893A4 (fr) Composition médicamenteuse pour traiter la leucémie et son procédé de préparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20180228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1249441

Country of ref document: HK

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190215

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/107 20060101ALI20190211BHEP

Ipc: A61K 31/122 20060101ALI20190211BHEP

Ipc: A61K 47/34 20170101AFI20190211BHEP

Ipc: A61K 9/19 20060101ALI20190211BHEP

Ipc: A61K 31/337 20060101ALI20190211BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190917

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1249441

Country of ref document: HK